We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It ... Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It generates a majority of its revenue from the Nucleic Acid Production that focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples. Show more
Kunden von Lonza können jetzt auf die CleanCap® mRNA-Capping-Technologie von TriLink für die nicht-kommerzielle Nutzung zugreifen und so die weitere Entwicklung wichtiger mRNA-Therapeutika...
Les clients de Lonza peuvent désormais accéder à la technologie de capsulage de l’ARNm CleanCap® de TriLink à des fins non commerciales, ce qui permet de poursuivre le développement de...
Lonza customers can now access TriLink’s CleanCap® mRNA capping technology for non-commercial use, enabling further development of critical mRNA therapeutics TriLink BioTechnologies (TriLink®), a...
Un site cGMP rationalise le développement clinique et commercial de substances médicamenteuses à base d'ARNm ; Construit par des experts de l'ARNm et de l'industrie pour répondre à la demande de...
cGMP-Anlage optimiert klinische und kommerzielle mRNA-Arzneimittelentwicklung; Entwicklung der Anlage mithilfe von mRNA- und Branchenfachleuten, um den Bedarf an mRNA-basierten Arzneimitteln zu...
cGMP Facility Streamlines Clinical & Commercial mRNA Drug Substance Development; Built by mRNA & Industry Experts to Meet Demand for mRNA-based Medicine TriLink BioTechnologies...
SAN DIEGO, April 10, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators...
SAN DIEGO, March 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.44 | 5.67010309278 | 7.76 | 8.225 | 7.31 | 1629900 | 7.84735273 | CS |
| 4 | -0.3 | -3.52941176471 | 8.5 | 8.92 | 7.19 | 1980217 | 8.09757651 | CS |
| 12 | 2.66 | 48.0144404332 | 5.54 | 8.92 | 5.045 | 2812677 | 7.62063167 | CS |
| 26 | 1.33 | 19.3595342067 | 6.87 | 8.92 | 4.52 | 2564712 | 6.68984224 | CS |
| 52 | -5.67 | -40.8795962509 | 13.87 | 16.62 | 4.52 | 2634464 | 9.09664216 | CS |
| 156 | -31.1 | -79.1348600509 | 39.3 | 63.55 | 4.52 | 1968356 | 20.61933206 | CS |
| 260 | -22.91 | -73.6419157827 | 31.11 | 63.55 | 4.52 | 1899065 | 21.76642976 | CS |
Monksdream
2 months ago
Monksdream
2 months ago
crudeoil24
3 years ago
crudeoil24
3 years ago
crudeoil24
3 years ago
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
